512 related articles for article (PubMed ID: 17853946)
1. TREM-1--expressing intestinal macrophages crucially amplify chronic inflammation in experimental colitis and inflammatory bowel diseases.
Schenk M; Bouchon A; Seibold F; Mueller C
J Clin Invest; 2007 Oct; 117(10):3097-106. PubMed ID: 17853946
[TBL] [Abstract][Full Text] [Related]
2. Intervention of an inflammation amplifier, triggering receptor expressed on myeloid cells 1, for treatment of autoimmune arthritis.
Murakami Y; Akahoshi T; Aoki N; Toyomoto M; Miyasaka N; Kohsaka H
Arthritis Rheum; 2009 Jun; 60(6):1615-23. PubMed ID: 19479878
[TBL] [Abstract][Full Text] [Related]
3. TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses.
Colonna M; Facchetti F
J Infect Dis; 2003 Jun; 187 Suppl 2():S397-401. PubMed ID: 12792857
[TBL] [Abstract][Full Text] [Related]
4. Reactivation of inflammatory bowel disease in a mouse model of depression.
Ghia JE; Blennerhassett P; Deng Y; Verdu EF; Khan WI; Collins SM
Gastroenterology; 2009 Jun; 136(7):2280-2288.e1-4. PubMed ID: 19272381
[TBL] [Abstract][Full Text] [Related]
5. Blocking TREM-1 signaling prolongs survival of mice with Pseudomonas aeruginosa induced sepsis.
Wang F; Liu S; Wu S; Zhu Q; Ou G; Liu C; Wang Y; Liao Y; Sun Z
Cell Immunol; 2012; 272(2):251-8. PubMed ID: 22055202
[TBL] [Abstract][Full Text] [Related]
6. Induction of triggering receptor expressed on myeloid cells 1 in murine resident peritoneal macrophages by monosodium urate monohydrate crystals.
Murakami Y; Akahoshi T; Hayashi I; Endo H; Kawai S; Inoue M; Kondo H; Kitasato H
Arthritis Rheum; 2006 Feb; 54(2):455-62. PubMed ID: 16447220
[TBL] [Abstract][Full Text] [Related]
7. Triggering receptor expressed on myeloid cells-1 (TREM-1) amplifies the signals induced by the NACHT-LRR (NLR) pattern recognition receptors.
Netea MG; Azam T; Ferwerda G; Girardin SE; Kim SH; Dinarello CA
J Leukoc Biol; 2006 Dec; 80(6):1454-61. PubMed ID: 16940328
[TBL] [Abstract][Full Text] [Related]
8. Azithromycin acts as an immunomodulatory agent to suppress the expression of TREM-1 in Bacillus pyocyaneus-induced sepsis.
Tong J; Liu ZC; Wang DX
Immunol Lett; 2011 Aug; 138(2):137-43. PubMed ID: 21507332
[TBL] [Abstract][Full Text] [Related]
9. Blockade of TREM-2 exacerbates experimental autoimmune encephalomyelitis.
Piccio L; Buonsanti C; Mariani M; Cella M; Gilfillan S; Cross AH; Colonna M; Panina-Bordignon P
Eur J Immunol; 2007 May; 37(5):1290-301. PubMed ID: 17407101
[TBL] [Abstract][Full Text] [Related]
10. TREM-1 amplifies inflammation and is a crucial mediator of septic shock.
Bouchon A; Facchetti F; Weigand MA; Colonna M
Nature; 2001 Apr; 410(6832):1103-7. PubMed ID: 11323674
[TBL] [Abstract][Full Text] [Related]
11. TREM-1 inhibition attenuates inflammation and tumor within the colon.
Zhou J; Chai F; Lu G; Hang G; Chen C; Chen X; Shi J
Int Immunopharmacol; 2013 Oct; 17(2):155-61. PubMed ID: 23810411
[TBL] [Abstract][Full Text] [Related]
12. Silencing of triggering receptor expressed on myeloid cells-2 enhances the inflammatory responses of alveolar macrophages to lipopolysaccharide.
Gao X; Dong Y; Liu Z; Niu B
Mol Med Rep; 2013 Mar; 7(3):921-6. PubMed ID: 23314916
[TBL] [Abstract][Full Text] [Related]
13. The role of granulocyte macrophage-colony-stimulating factor in acute intestinal inflammation.
Xu Y; Hunt NH; Bao S
Cell Res; 2008 Dec; 18(12):1220-9. PubMed ID: 19030026
[TBL] [Abstract][Full Text] [Related]
14. The therapeutic potential of TREM-1 modulation in the treatment of sepsis and beyond.
Gibot S
Curr Opin Investig Drugs; 2006 May; 7(5):438-42. PubMed ID: 16729720
[TBL] [Abstract][Full Text] [Related]
15. Animal models of intestinal inflammation: clues to the pathogenesis of inflammatory bowel disease.
Powrie F; Uhlig H
Novartis Found Symp; 2004; 263():164-74; discussion 174-8, 211-8. PubMed ID: 15669641
[TBL] [Abstract][Full Text] [Related]
16. Relationships between genetic polymorphisms of triggering receptor expressed on myeloid cells-1 and inflammatory bowel diseases in the Korean population.
Jung ES; Kim SW; Moon CM; Shin DJ; Son NH; Kim ES; Lee HJ; Hong SP; Kim TI; Kim WH; Cheon JH
Life Sci; 2011 Aug; 89(9-10):289-94. PubMed ID: 21763322
[TBL] [Abstract][Full Text] [Related]
17. The bile acid receptor FXR is a modulator of intestinal innate immunity.
Vavassori P; Mencarelli A; Renga B; Distrutti E; Fiorucci S
J Immunol; 2009 Nov; 183(10):6251-61. PubMed ID: 19864602
[TBL] [Abstract][Full Text] [Related]
18. Elevated levels of serum-soluble triggering receptor expressed on myeloid cells-1 in patients with IBD do not correlate with intestinal TREM-1 mRNA expression and endoscopic disease activity.
Saurer L; Rihs S; Birrer M; Saxer-Seculic N; Radsak M; Mueller C;
J Crohns Colitis; 2012 Oct; 6(9):913-23. PubMed ID: 22410349
[TBL] [Abstract][Full Text] [Related]
19. Effects of the TREM-1 pathway modulation during mesenteric ischemia-reperfusion in rats.
Gibot S; Massin F; Alauzet C; Montemont C; Lozniewski A; Bollaert PE; Levy B
Crit Care Med; 2008 Feb; 36(2):504-10. PubMed ID: 18091551
[TBL] [Abstract][Full Text] [Related]
20. The opioid antagonist naltrexone improves murine inflammatory bowel disease.
Matters GL; Harms JF; McGovern C; Fitzpatrick L; Parikh A; Nilo N; Smith JP
J Immunotoxicol; 2008 Apr; 5(2):179-87. PubMed ID: 18569389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
